Lucy Day
Finanzdirektor/CFO bei AN2 THERAPEUTICS, INC.
Vermögen: 69 830 $ am 30.04.2024
Aktive Positionen von Lucy Day
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AN2 THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.11.2019 | - |
Karriereverlauf von Lucy Day
Ehemalige bekannte Positionen von Lucy Day
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ANACOR PHARMACEUTICALS INC | Finanzdirektor/CFO | 01.03.2002 | 01.08.2016 |
| Personalreferent | 01.03.2002 | 01.08.2016 | |
| Centaur Pharmaceuticals, Inc. | Finanzdirektor/CFO | 01.02.1994 | 01.01.2002 |
| MERRILL LYNCH PREFERRED CAPITAL TRUST I | Corporate Officer/Principal | 01.01.1990 | 01.01.1994 |
Ausbildung von Lucy Day
| University of California, Berkeley | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Director of Finance/CFO | 3 |
| Human Resources Officer | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AN2 THERAPEUTICS, INC. | Health Technology |
| MERRILL LYNCH PREFERRED CAPITAL TRUST I | Finance |
| Private Unternehmen | 2 |
|---|---|
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
| Centaur Pharmaceuticals, Inc. | Health Technology |
